BIOTEKNOLOGIRÅDET

What BIOTEKNOLOGIRÅDET does

Bioteknologirådet (The Norwegian Biotechnology Advisory Board) is an independent advisory body established under Norwegian law (genteknologiloven and bioteknologiloven) to evaluate the social and ethical consequences of modern biotechnology on humans, animals, plants, and microorganisms. Founded in the early 1990s (firmographics cite 1991; an internal timeline cites 1993) and headquartered at Edvard Griegs vei 3B in Bergen, Norway, the organization is composed of 15 board members and 5 deputy members appointed by the Norwegian government, supported by a secretariat of approximately 8 employees. It functions as Norway's primary consultation body for government ministries and regulatory agencies on biotechnology policy, with a stated mandate to advise on the ethical use of biotechnology.

The organization operationalizes its mandate through a portfolio of non-commercial content channels: the free quarterly journal GENialt (in print and PDF), the monthly Biotekpodden podcast distributed on Apple Podcasts and Spotify, comprehensive thematic topic pages covering CRISPR, gene therapy, assisted reproduction, stem cells, synthetic biology, DNA forensics, personalized medicine, and bioeconomy, formal policy statements (Uttalelser) including BSE assessments for GMO products, and public events such as Bioteknologidagen, Arendalsuka participation, and monthly breakfast meetings. It also produces educational resources for primary and secondary schools, including the SmåGENialt youth series and teacher course offerings aligned with natural sciences curricula.

Bioteknologirådet is government-funded through the Norwegian state budget rather than commercial revenue. It sells no products or services; all publications, podcasts, and advisory outputs are provided free of charge. Its primary stakeholders are Norwegian government ministries and regulatory bodies, with secondary engagement targeting the healthcare and research community, schools and educators, and the general public. The organization has no private ownership, no subsidiaries, no external investment structure, and no app, API, or proprietary technology platform — it is an advisory and content operation, not a technology company.

Name

BIOTEKNOLOGIRÅDET

Legal name

Bioteknologirådet

Website

https://bioteknologiradet.no

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioteknologirådet (The Norwegian Biotechnology Advisory Board) is an independent government-appointed advisory body that evaluates the ethical and social consequences of modern biotechnology and serves Norwegian authorities and the public through publications, podcasts, and educational resources.

Ownership category

akta.pro rank

Headquarters

HQ city

Bergen

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Government Funding: As a Norwegian government-appointed advisory body, the organization receives public funding to fulfill its mandate of evaluating ethical use of biotechnology and providing guidance to authorities and the public.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Bioteknologirådet is an independent Norwegian government advisory board that evaluates the ethical and social consequences of modern biotechnology on humans, animals, plants, and microorganisms. It provides authoritative consultation statements to Norwegian authorities and publishes educational content including the quarterly journal GENialt, the Biotekpodden podcast, topic pages, and resources for schools. The organization operates without commercial revenue, distributing all resources free to the public.

Product overview

Bioteknologirådet (The Norwegian Biotechnology Advisory Board) is an independent advisory body, not a commercial product company. It provides public information and advisory services on biotechnology ethics through multiple channels: the quarterly journal GENialt, the Biotekpodden podcast, educational resources for schools (Temasider), public events (Arrangementer), and official policy statements (Uttalelser). The organization focuses on evaluating social and ethical consequences of modern biotechnology across humans, animals, plants, and microorganisms.

Differentiator

Problem solved

Functional benefit

Brands

• GENialt: Free quarterly journal published by Bioteknologirådet covering ethical and societal aspects of modern biotechnology
• Biotekpodden

Products and services

• GENialt Journal Free quarterly journal published by Bioteknologirådet covering ethical and societal aspects of modern biotechnology, available in Norwegian with free paper subscription and PDF versions online.
• Biotekpodden Podcast

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered minor and moderate.

• BIFF (Bergen International Film Festival)minorGTM or Marketing Partner · 20 October 2025Co-organized a film screening of '9-MONTH CONTRACT' with panel discussion on surrogacy, combining film and expert dialogue on biotechnology ethics.
• HjernerådetminorStrategic or Co-development Partner · 11 August 2025Collaborated on a joint event titled 'Håp, hype og hjernedata' (Hope, hype and brain data) to discuss future neurotechnology and its societal implications.
• BellonamoderateStrategic or Co-development Partner · 29 April 2025Jointly organized an open meeting titled 'Norges nye næringer' (Norway's new industries) with Bioteknologirådet and SINTEF to discuss sustainable industries and new economic opportunities beyond oil and gas.
• SINTEF IndustrimoderateStrategic or Co-development Partner · 29 April 2025Partnered with Bellona and Bioteknologirådet to organize an open meeting on Norway's new industries, bringing together experts from academia and industry to discuss sustainable economic development.

Scale indicators4 records

Recent moves5 records

Expansion highlights1 record

Direct peers

• Danish Council on Ethics (Det Etiske Råd): Denmark's national ethics council advising parliament and government on bioethical, healthcare, and emerging-technology issues — same Nordic governmental advisory function with overlapping mandate on biotechnology and genetic engineering.
• European Group on Ethics in Science and New Technologies (EGE): Independent EU-level advisory group on ethics in science and new technologies, providing opinions to the European Commission — analogous supranational advisory function to Bioteknologirådet's national mandate.
• French Comité Consultatif National d'Éthique (CCNE): France's national bioethics advisory body issuing opinions on biomedical and biotechnology ethics — directly comparable European peer with a long-standing government-mandated advisory role.
• German Ethics Council (Deutscher Ethikrat): Germany's national ethics council advising parliament and government on ethical questions including genetic engineering and biomedicine — directly comparable statutory advisory function with public-facing outputs.
• Swedish National Council on Medical Ethics (Smer): Swedish government advisory body on medical and bioethical questions including genetic testing and assisted reproduction — directly comparable Nordic peer covering similar biotechnology policy topics.
• Nuffield Council on Bioethics: UK-based independent bioethics advisory body that publishes reports and convenes policy dialogue on emerging biotechnologies — directly comparable in mandate, scope, and non-commercial government-independent status to Bioteknologirådet.

Broad incumbents

• The Hastings Center: US-based bioethics research institute producing influential scholarship on biotechnology ethics — comparable in subject-matter authority but operates as an independent research organization rather than a government-mandated advisory body.
• UNESCO International Bioethics Committee (IBC): International bioethics advisory body producing declarations and reports on biotechnology and human rights — comparable in function but at global multilateral scale rather than national advisory.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/bioteknologiradet

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOTEKNOLOGIRÅDET